The purpose of this program are to complete the development of electrically powered, totally implantable artificial heart (TAH) systems and establish the reliability, performance and manufacturability of these TAH systems as a prerequisite to consideration for an NHLBI Clinical Trial. Phase I (3 years; up to four contracts) comprises design completion, demonstration of manufacturability, performance testing in animals and demonstration of the contractor's capability to begin Phase II device readiness testing. Phase II (4 years; less than four contracts) will provide support for those contractors who successfully complete Phase I and are judged meritorious by peer-review. Phase II consists of in vitro reliability and in vivo animal testing of tether-free implantable total artificial heart systems.

Agency
National Institute of Health (NIH)
Institute
Division of Heart And Vascular Diseases (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HV038128-011
Application #
6352486
Study Section
Project Start
1993-09-30
Project End
2001-12-31
Budget Start
2000-09-14
Budget End
2000-12-31
Support Year
Fiscal Year
2000
Total Cost
$364,312
Indirect Cost
Name
Abiomed, Inc.
Department
Type
DUNS #
050636737
City
Danvers
State
MA
Country
United States
Zip Code
01923